These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11259521)

  • 1. 2001 ASPET Otto Krayer Award Lecture. Molecular targets for antiviral agents.
    De Clercq E
    J Pharmacol Exp Ther; 2001 Apr; 297(1):1-10. PubMed ID: 11259521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective virus inhibitors.
    De Clercq E
    Microbiologica; 1990 Apr; 13(2):165-78. PubMed ID: 1693749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hamao Umezawa Memorial Award Lecture: "An Odyssey in the Viral Chemotherapy Field".
    De Clercq E
    Int J Antimicrob Agents; 2001 Oct; 18(4):309-28. PubMed ID: 11691563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in antiviral drug design, discovery and development in 2004.
    Meanwell NA; Belema M; Carini DJ; D'Andrea SV; Kadow JF; Krystal M; Naidu BN; Regueiro-Ren A; Scola PM; Sit SY; Walker MA; Wang T; Yeung KS
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):307-400. PubMed ID: 16535860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
    Magee WC; Evans DH
    Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging antiviral drugs.
    De Clercq E
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):393-416. PubMed ID: 18764719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highlights in the development of new antiviral agents.
    De Clercq E
    Mini Rev Med Chem; 2002 Apr; 2(2):163-75. PubMed ID: 12370077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.
    Melegari M; Scaglioni PP; Wands JR
    Hepatology; 1998 Feb; 27(2):628-33. PubMed ID: 9462667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of virus replication: recent developments and prospects.
    Magden J; Kääriäinen L; Ahola T
    Appl Microbiol Biotechnol; 2005 Mar; 66(6):612-21. PubMed ID: 15592828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoralaninate pronucleotides of pyrimidine methylenecyclopropane analogues of nucleosides: synthesis and antiviral activity.
    Ambrose A; Zemlicka J; Kern ER; Drach JC; Gullen E; Cheng YC
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1763-74. PubMed ID: 16438046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies in the design of antiviral drugs.
    De Clercq E
    Nat Rev Drug Discov; 2002 Jan; 1(1):13-25. PubMed ID: 12119605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach.
    Esimone CO; Grunwald T; Nworu CS; Kuate S; Proksch P; Uberla K
    Chemotherapy; 2009; 55(2):119-26. PubMed ID: 19155620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogues of acyclic nucleosides derived from tris-(hydroxymethyl)phosphine oxide or bis-(hydroxymethyl)phosphinic acid coupled to DNA nucleobases.
    Nawrot B; Michalak O; De Clercq E; Stec WJ
    Antivir Chem Chemother; 2004 Nov; 15(6):319-28. PubMed ID: 15646645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy: old and current issues.
    Antonelli G; Turriziani O
    Int J Antimicrob Agents; 2012 Aug; 40(2):95-102. PubMed ID: 22727532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.
    Zhou S; Breitenbach JM; Borysko KZ; Drach JC; Kern ER; Gullen E; Cheng YC; Zemlicka J
    J Med Chem; 2004 Jan; 47(3):566-75. PubMed ID: 14736238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
    Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
    Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.